Companion Animal Drugs Market Size, Share, and Trends 2024 to 2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Companion Animal Drugs Market 

5.1. COVID-19 Landscape: Companion Animal Drugs Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Companion Animal Drugs Market, By Product

8.1. Companion Animal Drugs Market Revenue and Volume Forecast, by Product, 2024-2033

8.1.1. Drugs

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Vaccines

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

8.1.3. Medicated Feed Additives

8.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. Global Companion Animal Drugs Market, By Animal Type

9.1. Companion Animal Drugs Market Revenue and Volume Forecast, by Animal Type, 2024-2033

9.1.1. Dogs

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Cats

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

9.1.3. Horses

9.1.3.1. Market Revenue and Volume Forecast (2021-2033)

9.1.4. Others

9.1.4.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. Global Companion Animal Drugs Market, By Route of Administration 

10.1. Companion Animal Drugs Market Revenue and Volume Forecast, by Route of Administration, 2024-2033

10.1.1. Oral

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. Injectable

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

10.1.3. Topical

10.1.3.1. Market Revenue and Volume Forecast (2021-2033)

10.1.4. Others

10.1.4.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. Global Companion Animal Drugs Market, By Distribution Channel 

11.1. Companion Animal Drugs Market Revenue and Volume Forecast, by Distribution Channel, 2024-2033

11.1.1. Veterinary Hospitals

11.1.1.1. Market Revenue and Volume Forecast (2021-2033)

11.1.2. Veterinary Clinics

11.1.2.1. Market Revenue and Volume Forecast (2021-2033)

11.1.3. Pharmacy and Drug Stores

11.1.3.1. Market Revenue and Volume Forecast (2021-2033)

11.1.4. e-commerce

11.1.4.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 12. Global Companion Animal Drugs Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.1.2. Market Revenue and Volume Forecast, by Animal Type (2021-2033)

12.1.3. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

12.1.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.1.5.2. Market Revenue and Volume Forecast, by Animal Type (2021-2033)

12.1.5.3. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

12.1.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.1.6.2. Market Revenue and Volume Forecast, by Animal Type (2021-2033)

12.1.6.3. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

12.1.6.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.2.2. Market Revenue and Volume Forecast, by Animal Type (2021-2033)

12.2.3. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

12.2.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.2.5.2. Market Revenue and Volume Forecast, by Animal Type (2021-2033)

12.2.5.3. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

12.2.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.2.6.2. Market Revenue and Volume Forecast, by Animal Type (2021-2033)

12.2.6.3. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

12.2.6.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.2.7.2. Market Revenue and Volume Forecast, by Animal Type (2021-2033)

12.2.7.3. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

12.2.7.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.2.8.2. Market Revenue and Volume Forecast, by Animal Type (2021-2033)

12.2.8.3. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

12.2.8.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.3.2. Market Revenue and Volume Forecast, by Animal Type (2021-2033)

12.3.3. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

12.3.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.3.5.2. Market Revenue and Volume Forecast, by Animal Type (2021-2033)

12.3.5.3. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

12.3.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.3.6.2. Market Revenue and Volume Forecast, by Animal Type (2021-2033)

12.3.6.3. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

12.3.6.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.3.7.2. Market Revenue and Volume Forecast, by Animal Type (2021-2033)

12.3.7.3. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

12.3.7.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.3.8.2. Market Revenue and Volume Forecast, by Animal Type (2021-2033)

12.3.8.3. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

12.3.8.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.4.2. Market Revenue and Volume Forecast, by Animal Type (2021-2033)

12.4.3. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

12.4.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.4.5.2. Market Revenue and Volume Forecast, by Animal Type (2021-2033)

12.4.5.3. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

12.4.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.4.6.2. Market Revenue and Volume Forecast, by Animal Type (2021-2033)

12.4.6.3. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

12.4.6.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.4.7.2. Market Revenue and Volume Forecast, by Animal Type (2021-2033)

12.4.7.3. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

12.4.7.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.4.8.2. Market Revenue and Volume Forecast, by Animal Type (2021-2033)

12.4.8.3. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

12.4.8.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.5.2. Market Revenue and Volume Forecast, by Animal Type (2021-2033)

12.5.3. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

12.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.5.5.2. Market Revenue and Volume Forecast, by Animal Type (2021-2033)

12.5.5.3. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

12.5.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

12.5.6.2. Market Revenue and Volume Forecast, by Animal Type (2021-2033)

12.5.6.3. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

12.5.6.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

Chapter 13. Company Profiles

13.1. Indian Immunologicals Ltd

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Agrolabo S.p.A

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Endovac Animal Health

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. HIPRA

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Norbrook Holdings Limited

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Zoetis

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Chanelle Pharma

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Virbac SA

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Vetoquinol

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Merck & Co

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms